TipRanks
Go Ultimate55% OFF

BioPlus Co. Ltd. (099430) Stock Price & Analysis

099430 Stock Chart & Stats

$3,200.00-$210.00(-6.16%)
At close: 3:30 PM GMT+9
$3,250$3,500$3,7503 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$3,180.00 - $3,410.00
52-Week Range
$3,065.00 - $6,530.00
Previous Close
$3,410.00
Volume
N/A
Average Volume (3M)
136.72K
Market Cap
KRW 192.04B
Enterprise Value
KRW 314.09B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
14.1
Beta
0.29
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
2.19%

099430 FAQ

What was BioPlus Co. Ltd.’s price range in the past 12 months?
BioPlus Co. Ltd. lowest stock price was $3065.00 and its highest was $6530.00 in the past 12 months.
What is BioPlus Co. Ltd.’s market cap?
BioPlus Co. Ltd.’s market cap is ₩192.04B.
When is BioPlus Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioPlus Co. Ltd.’s earnings last quarter?
BioPlus Co. Ltd. released its earnings results on Aug 14, 2026. The company reported $33.182 earnings per share for the quarter.
Is BioPlus Co. Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BioPlus Co. Ltd. pay dividends?
BioPlus Co. Ltd. does not currently pay dividends.
What is BioPlus Co. Ltd.’s EPS estimate?
BioPlus Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioPlus Co. Ltd. have?
BioPlus Co. Ltd. has 61,640,720 shares outstanding.
What happened to BioPlus Co. Ltd.’s price movement after its last earnings report?
BioPlus Co. Ltd. reported an EPS of $33.182 in its last earnings report. Following the earnings report the stock price went up 1.247%.
Which hedge fund is a major shareholder of BioPlus Co. Ltd.?
Currently, no hedge funds are holding shares in KR:099430
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology